Skip to main content
TIBET AIM PHARM. INC. logo

TIBET AIM PHARM. INC. — Investor Relations & Filings

Ticker · 002826 ISIN · CNE100002C39 Shenzhen Stock Exchange Manufacturing
Open in API
Filings indexed 1,085 across all filing types
Latest filing 2022-04-21 Management Reports
Country CN China
Listing Shenzhen Stock Exchange 002826

About TIBET AIM PHARM. INC.

https://www.emyy.cn

Tibet Aim Pharm. Inc. is a pharmaceutical enterprise focused on the research, development, production, and distribution of medicinal products. The company integrates traditional Tibetan medicine with modern pharmaceutical manufacturing processes to develop a diverse portfolio of treatments. Its core product range typically includes cardiovascular medications, digestive system therapies, and specialized herbal formulations derived from high-altitude botanical sources. Tibet Aim Pharm. Inc. emphasizes the modernization of traditional formulas through rigorous clinical testing and standardized production techniques. The company serves healthcare providers and patients by providing therapeutic solutions that bridge ancient medical knowledge with contemporary scientific standards.

Recent filings

Filing Released Lang Actions
2021年度独立董事述职报告-郑斌
Management Reports Classification · 95% confidence The document is titled as the "2021年度独立董事述职报告" which translates to "2021 Annual Independent Director's Work Report." It details the independent director's attendance at board and shareholder meetings, participation in committees, independent opinions on various board matters, supervision of company governance, audit processes, and protection of shareholder rights during the 2021 fiscal year. The content is a detailed report of the independent director's duties and activities over the year rather than a general annual report or financial statement. It is not a full Annual Report (10-K) or Audit Report (AR), nor is it a brief announcement or proxy statement. The document is a management-related report focusing on the independent director's role and oversight, which fits best under Management Reports (MDA). The document length is 4291 characters, which is sufficient for a substantive report rather than a mere announcement. Therefore, the classification is Management Reports (MDA).
2022-04-21 Chinese
2021年度独立董事述职报告-宋瑞霖
Board/Management Information Classification · 95% confidence The document is titled as the "2021年度独立董事述职报告" which translates to "2021 Annual Independent Director's Work Report." It details the independent director's attendance at board and shareholder meetings, opinions on various board matters, supervision of company governance, audit processes, and protection of shareholder rights during the 2021 fiscal year. The content is a detailed report of the independent director's activities and opinions rather than an announcement or a brief summary. It does not contain financial statements or earnings data, so it is not an Annual Report (10-K) or Interim Report (IR). It is not a regulatory filing or certification letter. The document fits best under Board/Management Information (MANG) as it relates to the independent director's report on their duties and governance activities during the year.
2022-04-21 Chinese
2021年度独立董事述职报告-冯岚
Board/Management Information Classification · 95% confidence The document is titled as the '2021年度独立董事述职报告' which translates to '2021 Annual Independent Director's Work Report'. It details the independent director's attendance at board and shareholder meetings, opinions on board matters, supervisory activities, and training during the 2021 fiscal year. The content focuses on the independent director's duties, opinions, and governance oversight rather than presenting financial statements or audit results. The document length is 2900 characters, which is relatively short and consistent with a report or statement rather than a full annual report or audit report. It is not a certification or a brief announcement but a detailed director's report on their work and governance role. This fits best with the category of Board/Management Information (MANG), which includes announcements or reports related to board members and senior management activities, including independent director reports. Therefore, the classification is MANG with high confidence.
2022-04-21 Chinese
2022-017 关于回购注销2019年限制性股票激励计划部分限制性股票的公告
Transaction in Own Shares Classification · 95% confidence The document is an announcement regarding the company's repurchase and cancellation of restricted shares under the 2019 restricted stock incentive plan. It details the number of shares to be repurchased, the price, the reasons for repurchase, approvals from board and shareholders, and legal opinions. It does not contain financial statements or earnings data but focuses on share repurchase and capital structure changes. This fits the definition of a Transaction in Own Shares (POS) filing, which covers company buybacks or sales of its own shares. The document length is sufficient and contains detailed information about the repurchase transaction rather than just an announcement of a report or a certification. Therefore, the correct classification is POS with high confidence.
2022-04-21 Chinese
关于使用自有资金进行现金管理的公告
Capital/Financing Update Classification · 95% confidence The document is an announcement regarding the company's decision to use its own funds for cash management by investing in safe and liquid financial products. It includes details about the board meeting resolutions, supervisory board opinions, and independent director opinions. The document does not contain financial statements or detailed financial data but rather informs shareholders and the public about the company's cash management plan and related approvals. It is a regulatory announcement about financing activities but not a full capital or financing update report. Given the content and length (1779 characters), it fits best as a Capital/Financing Update (CAP) filing type.
2022-04-21 Chinese
2021年年度审计报告
Regulatory Filings
2022-04-21 Chinese

Browse filings by year

11 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.